Bio-View Ltd (BIOV) - Total Liabilities

Latest as of June 2025: ILA8.26 Million ILA ≈ $22.13K USD

Based on the latest financial reports, Bio-View Ltd (BIOV) has total liabilities worth ILA8.26 Million ILA (≈ $22.13K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check BIOV financial resilience to evaluate the company's liquid asset resilience ratio.

Bio-View Ltd - Total Liabilities Trend (2009–2024)

This chart illustrates how Bio-View Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Bio-View Ltd (BIOV) total assets.

Bio-View Ltd Competitors by Total Liabilities

The table below lists competitors of Bio-View Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Atossa Genetics Inc NASDAQ:ATOS	USA	$8.22 Million
IWG PLC LSE:IWG	UK	GBX10.23 Billion
MetaLabs Co Ltd KO:090370	Korea	₩99.06 Billion
Agricore CS Holdings Berhad KLSE:0309	Malaysia	RM25.01 Million
Photon Energy N.V. WAR:PEN	Poland	zł218.56 Million
TMD Energy Limited NYSE MKT:TMDE	USA	$102.33 Million
Bannari Amman Spinning Mills Limited NSE:BASML	India	Rs-4.74 Billion
Sidma S.A. Steel Products AT:SIDMA	Greece	€142.27 Million

Liability Composition Analysis (2009–2024)

This chart breaks down Bio-View Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Bio-View Ltd to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.41	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.29	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bio-View Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bio-View Ltd (2009–2024)

The table below shows the annual total liabilities of Bio-View Ltd from 2009 to 2024.

Year	Total Liabilities	Change
2024-12-31	ILA10.68 Million ≈ $28.62K	-27.12%
2023-12-31	ILA14.65 Million ≈ $39.28K	+7.31%
2022-12-31	ILA13.65 Million ≈ $36.60K	+6.18%
2021-12-31	ILA12.86 Million ≈ $34.47K	+45.77%
2020-12-31	ILA8.82 Million ≈ $23.65K	-26.70%
2019-12-31	ILA12.03 Million ≈ $32.26K	+12.88%
2018-12-31	ILA10.66 Million ≈ $28.58K	-5.30%
2017-12-31	ILA11.26 Million ≈ $30.18K	+1.39%
2016-12-31	ILA11.10 Million ≈ $29.77K	+6.85%
2015-12-31	ILA10.39 Million ≈ $27.86K	-19.72%
2014-12-31	ILA12.94 Million ≈ $34.70K	+6.16%
2013-12-31	ILA12.19 Million ≈ $32.69K	-7.14%
2012-12-31	ILA13.13 Million ≈ $35.20K	-8.26%
2011-12-31	ILA14.31 Million ≈ $38.37K	+7.74%
2010-12-31	ILA13.29 Million ≈ $35.62K	+1.23%
2009-12-31	ILA13.12 Million ≈ $35.18K	--

About Bio-View Ltd

TA:BIOV Israel Medical Devices

Market Cap

$27.74 Million

ILA10.35 Billion ILA

Market Cap Rank

#25137 Global

#360 in Israel

Share Price

ILA79.90

Change (1 day)

-4.20%

52-Week Range

ILA11.90 - ILA131.90

All Time High

ILA5076.00